MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY

This adverse event was reported 11 times

These drugs are most commonly taken by patients reporting MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY:

# Drug Count
0 PYRAZINAMIDE 5
1 AZATHIOPRINE 4
2 BUDESONIDE 4
3 ISONIAZID 4
4 RIFAMPICIN 3
5 FOLIC ACID 1
6 FOSCARBIDOPA/FOSLEVODOPA 1
7 LOPERAMIDE HYDROCHLORIDE 1
8 LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE 1
9 RIFAMPIN 1
See all common drugs associated with MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY

MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PYRAZINAMIDE 5 0.0005
1 RIFAMPICIN 3 0.0003
2 ISONIAZID 4 0.0002
3 FOSCARBIDOPA/FOSLEVODOPA 1 0.0001
4 ROTIGOTINE 1 0.0001
5 RIFAMPIN 1 0.0001
6 AZATHIOPRINE 4 0.0000
7 LOPERAMIDE HYDROCHLORIDE 1 0.0000
8 FOLIC ACID 1 0.0000
See all drugs enriched for association with MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY

MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimycobacterial [EPC] 5 0.0002
1 Nonergot Dopamine Agonist [EPC] 1 0.0001
2 Purine Antimetabolite [EPC] 4 0.0000
3 Rifamycin Antibacterial [EPC] 1 0.0000
4 Vitamin D [EPC] 1 0.0000
5 Corticosteroid [EPC] 4 0.0000
6 Vitamin B12 [EPC] 1 0.0000
7 Vitamin C [EPC] 1 0.0000
See all drug classes enriched for association with MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY